1 - 25 of 1
Number of results to display per page
TitleCreatorDescriptionIdentifier
1 Health-Related Quality of Life in Patients With Giant Cell Arteritis Treated With TocilizumabVibeke Strand, Sophie Dimonaco, Katie Tuckwell, Micki Klearman, Neil Collinson, John StoneSuperior rates of sustained glucocorticoid-free remission were shown in patients with giant cell arteritis (GCA) treated with weekly (QW) or every-other-week subcutaneous tocilizumab 162 mg+26-week prednisone taper (TCZ+26) for 52 weeks compared with placebo+26-week or 52-week prednisone taper (PBO+...20180306_nanos_posters_216
1 - 25 of 1